Predoctoral Researcher - Precision Nutrition for Cancer

IMDEA Food Institute; España; On-site; EUR 24,000 - 26,000; Full time

Job summary

IMDEA Food Institute in Spain invites applications for a predoc researcher to join the ONLIFE project, aiming at precision nutrition for oncology patients. The position leads to a doctoral thesis and spans up to four years, with a full-time contract and a 37.5-hour work week.

The work covers immunometabolic phenotyping of cancer patients, design of nutrition strategies, pilot interventions, and the evaluation of GLP-1 therapies, with data integration into the group’s digital tools and

Qualifications

• Candidate must have training in biochemistry, biotechnology, molecular/cell biology, immunology or oncology relevant to the project.
• Hands-on mammalian cell culture (BSL-2) experience required.
• Experience with functional immunological and metabolic assays and data analysis software.

Responsibilities

• Characterise the immunometabolic phenotype of cancer patients at different disease stages.
• Design and validate precision-nutrition strategies using cell models and advanced in vitro systems.
• Participate in pilot nutritional intervention studies in cancer patients and survivors.
• Study the influence of GLP-1-based therapies on immunometabolic profile and cancer.
• Process and analyse biological samples and integrate data into digital tools.
• Prepare manuscripts, present at conferences, and contribute to doctoral training.

Skills

Biochemistry

Molecular biology

Immunology

Cell culture

Data analysis (R/Python)

Education

Master degree or equivalent

Tools

Flow cytometry

Seahorse XF

GraphPad

ImageJ

CytExpert

Wave

R/Python

Job description

IMDEA Food Institute in Spain invites applications for a predoc researcher to join the ONLIFE project, aiming at precision nutrition for oncology patients. The position leads to a doctoral thesis and spans up to four years, with a full-time contract and a 37.5-hour work week.

The work covers immunometabolic phenotyping of cancer patients, design of nutrition strategies, pilot interventions, and the evaluation of GLP-1 therapies, with data integration into the group’s digital tools and